EFPIA - NEWSLETTER

EFPIA Newsletter 05 November 2020

Report: Without orphan drugs law, 2mn patients deprived access to therapies

In the absence of the EU orphan drugs regulation, which focuses on rare diseases, approximately two million patients would not get access to therapies, a new industry-funded report has found.

19 Conversations | The EFPIA podcast series

05 November 2020 Podcast: How can we keep SMEs in Europe?

Welcome to 19 conversations

Blogs

04 November 2020 COVID-19 vaccines: a watershed moment for science

An interview with Magdalena de Azero, Executive Director, Vaccines Europe

04 November 2020 October Liver Cancer Awareness Month, together we are stronger!

ELPA devotes each year the whole month of October to share awareness, information, and essential data regarding HCC...

04 November 2020 Rethinking liver cancer: Care for your liver like it cares for you

Is your liver working too hard?

03 November 2020 IMI Impact: collaboration is key to dementia challenge

More than 20 Innovative Medicines Initiative projects are helping advance dementia research

Did you miss our past virtual events? Watch them again!

Orphan Medicines: how to sustain innovation in an area of high unmet need?

How can we ensure access to new treatments today, medical innovation for tomorrow and sustainable healthcare systems in a globally competitive Europe?

Everything You Always Wanted to Know About Drug Shortages (But were afraid to ask)

We all share the same objective: ensuring that patients get the medicines and vaccines they need in a timely way.
How to achieve this - and, indeed, how to continue achieving this during a pandemic - is something that is top of the current EU agenda.

Events

09 NOV 2020

International Congress on the Effects of COVID-19 on People with Rare Diseases Virtual event

New Share4Rare event! On the second week of November, an international conference will take place virtually in order...

Learn more →

10 NOV 2020

IMI Stakeholder Forum 2020 Virtual event

The theme this year is 'Broader horizons: growing Europe’s health partnership'.

Learn more →

12 NOV 2020

12 NOV - Everything You Always Wanted to Know About Drug Shortages (But were afraid... Virtual event

How can policy promote robust and resilient European supply chains as part of a global framework?

Learn more →

20 NOV 2020

From silo budgeting to financial integration: Where does the EU stand in diabetes... Online event

Lessons learned from an EFPIA/The Economist Intelligence Unit study

Learn more →

We published

Strengthening Health Systems Through Smart Spending 15 October 2020 (Publications)

EFPIA has developed a number of policy recommendations for national and European policy-makers to inform a discussion...

What we are reading

Estimated impact of EU Orphan Regulation on incentives for innovation 30 October 2020 (Dolon)

2020 EU Health Summit Videos 26 October 2020 (EU Health Coalition)

Covid vaccine tracker: when will a coronavirus vaccine be ready? 20 October 2020 (The Guardian)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶